MRNY

YieldMax MRNA Option Income Strategy ETF (MRNY) | Rumor.io

YieldMax MRNA Option Income Strategy ETF

MRNY

Attention (50-day avg)0.01%

Attention rank (50-day avg)#407

Bullish sentiment (50-day avg)98%

Price to earnings ratio0

Net assets0

Expense ratio0.01%

Social

What share of all ETF conversation is about MRNY?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0.01% +0.01	0.01% -0.01	0.01% 0

Aug 19

Moderna's personalized mRNA cancer vaccine showed significant results in a late-stage clinical trial, slowing the return and spread of melanoma.
$MRNY has experienced significant gains, rising by 32% since an alert at 9:32 AM ET, and is now trading at $39.15.
The ETF has been a consistent payer, with one investor holding onto their shares despite the rapid increase in value.

Generated by AI

Sentiment

Of the messages about MRNY that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	100% +2.11	18.36% -69.97
Bearish	—	0%	0% -2.11	81.64% +69.97

Bullish· Aug 19

$MRNY has been a consistent payer, with a 22.77% return in just 2 months, making it an attractive option for investors.
The stock's recent price increase is largely due to the success of $MRNA, which had positive results for its cancer drug, exciting the market and driving up demand for $MRNY.
Investors who have been holding onto $MRNY for a while have been rewarded with significant returns, with one investor reporting a 40% gain since a specific alert.

Bearish· Nov 15

The YieldMax MRNA Option Income Strategy ETF ($MRNY) is experiencing destructive decay, which may indicate a decline in its value or performance.
The mention of destructive decay suggests that the ETF's underlying assets or strategies may be deteriorating, leading to a loss of investor confidence.
The comparison to other assets ($TSLY and $XYZY) implies that $MRNY is not performing well relative to its peers, which may further exacerbate its decline.

Generated by AI

Topics

Of the messages about MRNY that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Technical Analysis	—	100%	100%	99.32%
Macro	—	0%	0%	0.68%

Aug 19

The YieldMax MRNA Option Income Strategy ETF ($MRNY) has broken multiple resistance lines and is currently testing the pennant, with a strong need for volume to break the HOD at $101.29.
The ETF has shown a significant increase in value, up 147.3% with a strong move, but has a weak financial profile with a net margin of 0.0% and free cash flow of $0.00.
The ETF's strategy change has been a significant factor in its success, with the yield coming from the premium sold by the company, and some investors considering holding and taking the income rather than selling.

Generated by AI

Community

Of the messages about MRNY, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	83.61%	81.16%	31.98%
Newcomers	—	16.39%	18.84%	68.02%

Aug 19

The YieldMax MRNA Option Income Strategy ETF ($MRNY) is a high-yield stock that has been performing well, with a 22.77% return in two months and a 147.3% increase in its top gainer ranking.
Newcomers to the stock are confused about why it wasn't invested in earlier, with one user stating they invested with "0 conviction, 0 timing" but are still seeing a significant yield.
The stock's performance is being attributed to the positive results of Moderna's ($MRNA) cancer drug, with one user stating it's a "monumental shift for mRNA" and another warning that it may come back down quickly due to Moderna's history of pump and dumps.

Generated by AI

News

The Melanoma Win Is Real, The Price Isn't - Moderna And MRNY Both Sell (NASDAQ:MRNA)

Moderna (MRNA) and MRNY are rated Sell on stretched valuation after melanoma Phase 3 news.

15d agoSeeking Alpha

MRNY: Options Income Strategy For Indirect Moderna Exposure (NYSEARCA:MRNY)

2mo agoSeeking Alpha

Also Discussed

Investors talking about MRNY also mention

#	Name	Attention
1	YieldMax AI Option Income Strategy ETFAIYY	0%new
2	YieldMax AMD Option Income Strategy ETFAMDY	0.03%new
3	YieldMax META Option Income Strategy ETFFBY	0%new
4	JPMO - YieldMax JPM Option Income Strategy ETF	——
5	YieldMax GOOGL Option Income Strategy ETFGOOY	0%new
6	YieldMax Universe Fund of Option Income ETFsYMAX	0.14%new
7	YieldMax XOM Option Income Strategy ETFXOMO	0%new
8	DISO - YieldMax DIS Option Income Strategy ETF	——
9	YieldMax MSFT Option Income Strategy ETFMSFO	0%0
10	YieldMax Magnificent 7 Fund of Option Income ETFsYMAG	0.05%+0.05

YieldMax MRNA Option Income Strategy ETF

YieldMax MRNA Option Income Strategy ETF is an actively managed exchange-traded fund designed to generate income from Moderna-related options exposure. The fund uses a synthetic covered call approach, primarily by selling call spreads linked to Moderna Inc., while holding cash and U.S. Treasury securities as collateral. Its strategy is intended to collect option premiums and distribute them to shareholders on a regular basis, while still allowing some participation in Moderna’s share price movements. The fund is focused on a single underlying company and is positioned within the derivative income segment of the ETF market. YieldMax MRNA Option Income Strategy ETF serves investors seeking a rules-based options income strategy centered on Moderna rather than direct ownership of the stock.

Location

United States

Social

What share of all ETF conversation is about MRNY?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0.01% +0.01	0.01% -0.01	0.01% 0

Aug 19

Moderna's personalized mRNA cancer vaccine showed significant results in a late-stage clinical trial, slowing the return and spread of melanoma.
$MRNY has experienced significant gains, rising by 32% since an alert at 9:32 AM ET, and is now trading at $39.15.
The ETF has been a consistent payer, with one investor holding onto their shares despite the rapid increase in value.

Generated by AI

Sentiment

Of the messages about MRNY that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	100% +2.11	18.36% -69.97
Bearish	—	0%	0% -2.11	81.64% +69.97

Bullish· Aug 19

$MRNY has been a consistent payer, with a 22.77% return in just 2 months, making it an attractive option for investors.
The stock's recent price increase is largely due to the success of $MRNA, which had positive results for its cancer drug, exciting the market and driving up demand for $MRNY.
Investors who have been holding onto $MRNY for a while have been rewarded with significant returns, with one investor reporting a 40% gain since a specific alert.

Bearish· Nov 15

The YieldMax MRNA Option Income Strategy ETF ($MRNY) is experiencing destructive decay, which may indicate a decline in its value or performance.
The mention of destructive decay suggests that the ETF's underlying assets or strategies may be deteriorating, leading to a loss of investor confidence.
The comparison to other assets ($TSLY and $XYZY) implies that $MRNY is not performing well relative to its peers, which may further exacerbate its decline.

Generated by AI

Topics

Of the messages about MRNY that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Technical Analysis	—	100%	100%	99.32%
Macro	—	0%	0%	0.68%

Aug 19

The YieldMax MRNA Option Income Strategy ETF ($MRNY) has broken multiple resistance lines and is currently testing the pennant, with a strong need for volume to break the HOD at $101.29.
The ETF has shown a significant increase in value, up 147.3% with a strong move, but has a weak financial profile with a net margin of 0.0% and free cash flow of $0.00.
The ETF's strategy change has been a significant factor in its success, with the yield coming from the premium sold by the company, and some investors considering holding and taking the income rather than selling.

Generated by AI

Community

Of the messages about MRNY, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	83.61%	81.16%	31.98%
Newcomers	—	16.39%	18.84%	68.02%

Aug 19

The YieldMax MRNA Option Income Strategy ETF ($MRNY) is a high-yield stock that has been performing well, with a 22.77% return in two months and a 147.3% increase in its top gainer ranking.
Newcomers to the stock are confused about why it wasn't invested in earlier, with one user stating they invested with "0 conviction, 0 timing" but are still seeing a significant yield.
The stock's performance is being attributed to the positive results of Moderna's ($MRNA) cancer drug, with one user stating it's a "monumental shift for mRNA" and another warning that it may come back down quickly due to Moderna's history of pump and dumps.

Generated by AI

YieldMax MRNA Option Income Strategy ETF

Social

Aug 19

Bullish· Aug 19

Bearish· Nov 15

Aug 19

Aug 19

The Melanoma Win Is Real, The Price Isn't - Moderna And MRNY Both Sell (NASDAQ:MRNA)

MRNY: Options Income Strategy For Indirect Moderna Exposure (NYSEARCA:MRNY)

Also Discussed

YieldMax MRNA Option Income Strategy ETF

Company Information

Location

The Melanoma Win Is Real, The Price Isn't - Moderna And MRNY Both Sell (NASDAQ:MRNA)

MRNY: Options Income Strategy For Indirect Moderna Exposure (NYSEARCA:MRNY)

Also Discussed

Social

Aug 19

Bullish· Aug 19

Bearish· Nov 15

Aug 19

Aug 19